Open Nav

ImCare Biotech

  • Aaron Lu, ImCare Biotech

Capital Raise, Companion Diagnostic/Commercial Partnership

  • Date:Thursday, October 18
  • Time:9:45 AM - 10:00 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:ImCare Biotech, LLC is a biotechnology company situated in Doylestown, PA. The company's primary products in development are innovative diagnostic biomarkers as well as developmental drugs for the treatment of liver diseases such as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Its leading product, HepatoDetect® is a serum based diagnostic immunoassay that is significantly more sensitive and specific in detecting liver cancer than existing generations of immunoassays and is effective for detecting HCC including in its early stages.
  • Company Website:www.imcarebiotech.com
  • Company HQ City:Doylestown
  • Company HQ Country:United States
  • Company HQ State:Pennsylvania           
  • CEO/Top Company Official:Aaron Lu
  • Year Founded:2011
  • Main Therapeutic Focus:Diagnostics
  • Lead Product in Development :HepatoDetect
  • Development Phase of Primary Product:Discovery
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :0
  • Previous and Current Investors:0
  • Size of Last Investment Round:0
  • Total Amount Raised to Date, In All Rounds:0
Speakers
Aaron Lu
ImCare Biotech
Back